All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Monoclonal antibodyPhase 22 trials

    Immunocore Ltd · Cancer, HLA-A*02:01-positive, Refractory Cancer

  • MR-VACPhase 22 trials

    GSK · Diarrhoea

  • MRG006APhase 22 trials

    Lepu Biopharma Co., Ltd. · Advanced Solid Tumors, Hepatocellular Carcinoma

  • MRT-2359Phase 22 trials

    Monte Rosa Therapeutics, Inc · Prostate Cancer, NSCLC, SCLC

  • MT-125Phase 22 trials

    Myosin Therapeutics Inc. · Glioblastoma (GBM), Glioblastoma

  • MWN109 4Phase 22 trials

    Shanghai Minwei Biotechnology Co., Ltd · Type 2 Diabetes Mellitus (T2DM), Overweight , Obesity

  • NBM-BMXPhase 22 trials

    Novelwise Pharmaceutical Corporation · Malignant Neoplasm of Brain, Malignant Neoplasm

  • NE3107bezisterimPhase 22 trials

    BioVie Inc. · Long COVID, Parkinsons Disease (PD)

  • NelistotugGSK6097608Phase 22 trials

    GSK · Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck

  • NelmastobartPhase 22 trials

    STCube, Inc. · Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer, Non Small Cell Lung Cancer

  • NEO100Perillyl alcoholPhase 22 trials

    Neonc Technologies, Inc. · Glioblastoma Multiforme, Residual, Progressive or Recurrent Grade II or III Meningioma

  • NKX019Phase 22 trials

    Nkarta, Inc. · Lupus Nephritis, Primary Membranous Nephropathy, Systemic Sclerosis

  • NLM-001Phase 22 trials

    Nelum Corp · Untreated, Advanced Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma

  • NNC0194-0499Phase 22 trials

    Novo Nordisk · Alcohol-related Liver Disease, Non-alcoholic Steatohepatitis

  • Normal Saline alongPhase 22 trials

    Pharmazz, Inc. · Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy

  • NS-863Phase 22 trials

    NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension

  • NT-0796Phase 22 trials

    NodThera Ltd. (a Rezera company) · Obesity and Type 2 Diabetes, Obesity

  • NT-101Phase 22 trials

    NexThera Co., Ltd. · Wet Age Related Macular Degeneration, Wet AMD

  • NWRD09Phase 22 trials

    Newish Biotech (Wuxi) Co., Ltd. · High-grade Squamous Intraepithelial Lesion (HSIL), Persistent HPV16 Infection

  • ODM-212Phase 22 trials

    Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer

  • of QLS1410Phase 22 trials

    Qilu Pharmaceutical Co., Ltd. · Hypertension (HTN), Uncontrolled Hypertension

  • of TQH2722Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Sinusitis, Chronic Rhinosinusitis

  • OfirnoflastHT-6184Phase 22 trials

    Halia Therapeutics, Inc. · Myelodysplastic Syndromes, Anemia, Myelodysplastic Syndrome

  • Olaptesed pegolNOX-A12Phase 22 trials

    TME Pharma AG · Metastatic Pancreatic Cancer, Glioblastoma

  • ONC206JZP3507Phase 22 trials

    Jazz Pharmaceuticals · Meningioma, Advanced Pheochromocytoma and Paraganglioma, PCPG

  • ONO-2020Phase 22 trials

    Ono Pharmaceutical Co., Ltd. · Agitation Associated With Alzheimer's Disease Dementia, Alzheimer Disease

  • OnvansertibPhase 22 trials

    Cardiff Oncology · Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation

  • OpRegenPhase 22 trials

    Roche (Genentech) · Age-Related Macular Degeneration, Geographic Atrophy

  • ORKA-001Phase 22 trials

    Oruka Therapeutics, Inc. · Plaque Psoriasis

  • ORX750Phase 22 trials

    Centessa Pharmaceuticals (UK) Limited · Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia

  • OsrhCTRecombinant Human Chymotrypsin 4000UPhase 22 trials

    Healthgen Biotechnology Corp. · Gastric Mucosal Lesion

  • PA9159 Metered-DosePhase 22 trials

    Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma

  • paridiprubartPhase 22 trials

    PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)

  • parsaclisibINCB050465Phase 22 trials

    Incyte · Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma, B-Cell Malignancies

  • Suzhou BlueHorse Therapeutics Co., Ltd. · Non-Small Cell Lung Cancer, Advanced Malignant Solid Tumor

  • Sanofi · Healthy Volunteers, Meningococcal Immunization, Meningococcal Immunisation

  • per day for 28 daysPhase 22 trials

    Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma

  • Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma

  • Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma

  • Seqker Biosciences, Inc. · Solid Tumors, Advanced Cancer, Recurrent Cancer

  • PEX010-Assisted TherapyPEX010Phase 22 trials

    Filament Health Corp. · Stimulant Use Disorder, Opioid Use Disorder

  • PF-07104091ovarian, SCLCPhase 22 trials

    Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer

  • PGN-EDODM1Phase 22 trials

    PepGen Inc · Myotonic Dystrophy 1

  • PM54Phase 22 trials

    PharmaMar · Advanced Solid Tumor, Advanced Malignancies

  • PRA-216Phase 22 trials

    Prana Therapies Inc · Chronic Obstructive Pulmonary Disease (COPD), Mild to Moderate Asthma

  • Prizloncabtagene AutoleucelC-CAR039Phase 22 trials

    AbelZeta Inc. · Large B Cell Lymphoma, LBCL, Diffuse Large B Cell Lymphoma (DLBCL)

  • ProgerininPhase 22 trials

    PRG Science & Technology Co., Ltd. · Werner Syndrome, Hutchinson-Gilford Progeria Syndrome

  • QHL-1618ALK-N001Phase 22 trials

    Zhejiang Anglikang Pharmaceutical Co., Ltd. · Advanced Gastrointestinal Tumors, Advanced Solid Tumors

  • QLC1401Phase 22 trials

    Qilu Pharmaceutical Co., Ltd. · Advanced Breast Cancer, Advanced ER+/HER2- Breast Cancer

  • QLH12016Phase 22 trials

    Qilu Pharmaceutical Co., Ltd. · Prostatic Neoplasms, Advanced Prostate Cancer

NewerPage 38 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.